This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smit, J. W. A. Articles by Goslings, B. M. Search for Related Content PubMed PubMed Citation Articles by Smit, J. W. A. Articles by Goslings, B. M.

Embolization for Vertebral Metastases of Follicular Thyroid Carcinoma

Departments of Endocrinology (J.W.A.S., B.M.G.) and Radiology (G.J.V.), Leiden University Medical Center, NL 2300 RC Leiden, The Netherlands

Address correspondence and requests for reprints to: Jan W. A. Smit, Department of Endocrinology, Leiden University Medical Center, P.O. Box 9600, NL 2300 RC Leiden, The Netherlands. E-mail: jsmit{at}mail

The technique of selective embolization has been applied for years in the treatment of vascular anomalies, severe hemorrhage and benign or malignant tumors, notably vertebral metastases of renal cell carcinoma. Because this technique is relatively easy to perform and offers immediate relief of symptoms, it is an attractive option for patients with vertebral metastases of thyroid carcinoma with signs of spinal cord compression. In these patients, other treatment modalities like radioactive iodine, external irradiation, or surgery are more cumbersome or less effective in the short term. We describe four patients with metastasized follicular thyroid carcinoma, presenting with neurological symptoms due to vertebral metastases. All patients had undergone total thyroidectomy, ranging from 1 month to 4 yr before embolization. Embolization was combined with iodine-131 therapy when appropriate. Selective catheterization of the arteries feeding the metastases was performed, followed by infusion of polyvinyl alcohol particles (Ivalon). The procedure was technically successful in all patients without adverse effects. In the patients described, embolization resulted in rapid resolution of neurological symptoms, sometimes within hours. The therapeutic effect lasted from months to years. We conclude that embolization of vertebral metastases of follicular thyroid carcinoma is an attractive palliative therapeutic option that may offer rapid relief of symptoms.

This article has been cited by other articles:

				H. Raef, T. Dahhan, M. Ahmed, M. Mubarak, T. Rana, and A. Tulba Recurrent thyroid storm induced by heretofore unrecognised causes in a patient with thyroid cancer BMJ Case Reports, April 14, 2009; 2009(apr14_1): bcr0720080442 - bcr0720080442. [Abstract] [Full Text]

				R. Kickuth, C. Waldherr, H. Hoppe, H. M. Bonel, K. Ludwig, M. Beck, and J. Triller Interventional Management of Hypervascular Osseous Metastasis: Role of Embolotherapy Before Orthopedic Tumor Resection and Bone Stabilization Am. J. Roentgenol., December 1, 2008; 191(6): W240 - W247. [Abstract] [Full Text] [PDF]

				M. Dedecjus, J. Tazbir, Z. Kaurzel, A. Lewinski, G. Strozyk, and J. Brzezinski Selective embolization of thyroid arteries as a preresective and palliative treatment of thyroid cancer Endocr. Relat. Cancer, September 1, 2007; 14(3): 847 - 852. [Abstract] [Full Text] [PDF]

				C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J. P. Travagli, B. Caillou, M. Ricard, J. D. Lumbroso, F. De Vathaire, et al. Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2892 - 2899. [Abstract] [Full Text] [PDF]

				M. N. Younes, O. G. Yigitbasi, Y. W. Park, S.-J. Kim, S. A. Jasser, V. S. Hawthorne, Y. D. Yazici, M. Mandal, B. N. Bekele, C. D. Bucana, et al. Antivascular Therapy of Human Follicular Thyroid Cancer Experimental Bone Metastasis by Blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor Phosphorylation Cancer Res., June 1, 2005; 65(11): 4716 - 4727. [Abstract] [Full Text] [PDF]

				C. F. A. Eustatia-Rutten, J. A. Romijn, M. J. Guijt, G. J. Vielvoye, R. van den Berg, E. P. M. Corssmit, A. M. Pereira, and J. W. A. Smit Outcome of Palliative Embolization of Bone Metastases in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3184 - 3189. [Abstract] [Full Text] [PDF]

				M.-O. Bernier, L. Leenhardt, C. Hoang, A. Aurengo, J.-Y. Mary, F. Menegaux, E. Enkaoua, G. Turpin, J. Chiras, G. Saillant, et al. Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1568 - 1573. [Abstract] [Full Text]